Predictive value of HER-2 and Topoisomerase IIα in response to primary doxorubicin in breast cancer
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Oncology
Reference35 articles.
1. Prognostic significance of a complete pathological response after induction chemotherapy in operable breast cancer;Chollet;Br J Cancer,2002
2. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene;Slamon;Science,1987
3. HER-2/neu gene amplification characterized by fluorescence in situ hybridization: poor prognosis in node-negative breast carcinomas;Press;J Clin Oncol,1997
4. HER-2/neu oncogene protein and prognosis in breast cancer;Tandon;J Clin Oncol,1989
5. c-erbB-2 expression and response to adjuvant therapy in women with node-positive early breast cancer;Muss;N Engl J Med,1994
Cited by 22 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. SCIPAC: quantitative estimation of cell-phenotype associations;Genome Biology;2024-05-13
2. Gene expression of hENT1, dCK, CDA, dCMPD and topoisomerase IIα as an indicator of chemotherapy response in AML treated with cytarabine and daunorubicin;Cancer Management and Research;2018-11
3. Pharmacogenetic variants and response to neoadjuvant single-agent doxorubicin or docetaxel;Pharmacogenetics and Genomics;2018-11
4. Practical consensus recommendations on management of HR + ve early breast cancer with specific reference to genomic profiling;South Asian Journal of Cancer;2018-04
5. Topoisomerase II Inhibitors and Poisons, and the Influence of Cell Cycle Checkpoints;Current Medicinal Chemistry;2017-06-30
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3